Dietary omega-6 lipids promote postinjury aberrant bone formation in obesity
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci205829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Stefanie L Moye und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery. Hauptthemen laut MEDLINE: Obesity, Fatty Acids, Omega-6, Ossification, Heterotopic, Mesenchymal Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIAMS, U.S. Department of Defense.
Abstract (Originalsprache)
Obesity is associated with impaired wound healing, but the mechanisms linking excess adiposity to aberrant tissue repair remain unresolved. Heterotopic ossification (HO) is a severe example of pathologic tissue repair in which mesenchymal progenitor cells (MPCs) undergo aberrant osteochondral differentiation within soft tissue, leading to joint contractures and pain. Here, we show that accumulation of dietary omega-6 (ω-6) lipids in the injury site is a key mechanism linking obesity to HO. Specifically, in mice fed a high-fat diet (HFD), injured tissues were enriched in linoleic and arachidonic acids, providing substrate for myeloid COX-2–dependent prostaglandin E 2 (PGE 2 ) production. PGE 2 then drove a transcriptional program in MPCs that promoted osteochondral differentiation. An isocaloric, low linoleic acid HFD reduced HO despite comparable obesity, demonstrating that dietary lipid composition, rather than adiposity alone, drove pathological repair. Clinical data mirrored these findings, showing that obesity conferred increased HO risk, and COX-2 inhibition reduced HO exclusively in obese patients. Together, these findings identify injury site ω-6 lipid enrichment as the key signal linking the diet to MPC reprogramming, pointing to dietary lipid modulation as an actionable strategy to limit HO in obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery.
- Medical Scientist Training Program.
- Department of Immunology, and.
- Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
Förderung
- NIAMS NIH HHS
- NIAMS
- U.S. Department of Defense
- CPRIT
Zitieren
APA
Moye, S. L., Mittal, M., Srinivasan, T., Korlakunta, S., Pagani, C. A., Dar, A., Geshow, O., Feist, D., Zacharias, L. G., Li, Z., James, A. W., Hoxhaj, G., Smith, A. M., Gallagher, K. A., Mathews, T. P., Tower, R. J., & Levi, B. (2026). Dietary omega-6 lipids promote postinjury aberrant bone formation in obesity. Journal of Clinical Investigation. https://doi.org/10.1172/jci205829
Vancouver
Moye SL, Mittal M, Srinivasan T, Korlakunta S, Pagani CA, Dar A, et al. Dietary omega-6 lipids promote postinjury aberrant bone formation in obesity. Journal of Clinical Investigation. 2026. doi:10.1172/jci205829
BibTeX
@article{Moye2026,
author = {Moye, Stefanie L and Mittal, Monisha and Srinivasan, Tarun and Korlakunta, Sneha and Pagani, Chase A and Dar, Ayelet and Geshow, Oromo and Feist, Dylan and Zacharias, Lauren G and Li, Zhao and James, Aaron W and Hoxhaj, Gerta and Smith, Andrew M and Gallagher, Katherine A and Mathews, Thomas P and Tower, Robert J and Levi, Benjamin},
title = {Dietary omega-6 lipids promote postinjury aberrant bone formation in obesity},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci205829}
}
EUVIMED